<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006163.pub2" GROUP_ID="ENDOC" ID="207705092210384489" MERGED_FROM="" MODIFIED="2009-03-23 11:18:33 +0100" MODIFIED_BY="Gudrun Paletta" REVIEW_NO="" REVMAN_SUB_VERSION="5.0.18" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.0">
<COVER_SHEET MODIFIED="2009-03-23 11:08:49 +0100" MODIFIED_BY="Gudrun Paletta">
<TITLE>Parenteral calcium for intensive care unit patients</TITLE>
<CONTACT>
<PERSON ID="7CF4938282E26AA201650CEABCFF18C5" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Matthew</FIRST_NAME>
<MIDDLE_INITIALS>R</MIDDLE_INITIALS>
<LAST_NAME>Rosengart</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>rosengartmr@upmc.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Surgery</DEPARTMENT>
<ORGANISATION>University of Pittsburgh</ORGANISATION>
<ADDRESS_1>F-1266.1, 200 Lothrop Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Pittsburgh</CITY>
<ZIP>PA 15213</ZIP>
<REGION/>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>+1 412 6470860</PHONE_1>
<PHONE_2/>
<FAX_1>+1 412 6471448</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2009-03-23 11:07:43 +0100" MODIFIED_BY="Gudrun Paletta">
<PERSON ID="7D0433E082E26AA201650CEA2EB7D944" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Raquel</FIRST_NAME>
<MIDDLE_INITIALS>M</MIDDLE_INITIALS>
<LAST_NAME>Forsythe</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>forsytherm@upmc.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Surgery</DEPARTMENT>
<ORGANISATION>University of Pittsburgh</ORGANISATION>
<ADDRESS_1>F-1266.2, 200 Lothrop Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Pittsburgh</CITY>
<ZIP>PA 15213</ZIP>
<REGION/>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>+1 412 6470860</PHONE_1>
<PHONE_2>+1 412 6470924</PHONE_2>
<FAX_1>+1 412 6471448</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="976848EE82E26AA20038D341CC74C98D" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Charles</FIRST_NAME>
<MIDDLE_INITIALS>B</MIDDLE_INITIALS>
<LAST_NAME>Wessel</LAST_NAME>
<SUFFIX/>
<POSITION>Faculty Liberarian</POSITION>
<EMAIL_1>cbw@pitt.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Health Sciences Library System</DEPARTMENT>
<ORGANISATION>University of Pittsburgh</ORGANISATION>
<ADDRESS_1>3550 Terrace Street ? 200 Scaife Hall</ADDRESS_1>
<ADDRESS_2/>
<CITY>Pittsburgh</CITY>
<ZIP>15261</ZIP>
<REGION>PA</REGION>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>+1 412 648 8730</PHONE_1>
<PHONE_2>+1 412 648 8796</PHONE_2>
<FAX_1>+1 412 648 8819</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7D07276E82E26AA201650CEA5298F22B" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Timothy</FIRST_NAME>
<MIDDLE_INITIALS>R</MIDDLE_INITIALS>
<LAST_NAME>Billiar</LAST_NAME>
<SUFFIX/>
<POSITION>Professor and Chair</POSITION>
<EMAIL_1>billiartr@upmc.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Surgery</DEPARTMENT>
<ORGANISATION>University of Pittsburgh</ORGANISATION>
<ADDRESS_1>F-1281 PUH, 200 Lothrop Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Pittsburgh</CITY>
<ZIP>PA 15213</ZIP>
<REGION/>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>+1 412 6471749</PHONE_1>
<PHONE_2>+1 412 6470250</PHONE_2>
<FAX_1>+1 412 6473247</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14377" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Derek</FIRST_NAME>
<MIDDLE_INITIALS>C</MIDDLE_INITIALS>
<LAST_NAME>Angus</LAST_NAME>
<SUFFIX/>
<POSITION>Director - CRISMA Laboratory</POSITION>
<EMAIL_1>angusdc@ccm.upmc.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Critical Care Medicine</DEPARTMENT>
<ORGANISATION>University of Pittsburgh School of Medicine</ORGANISATION>
<ADDRESS_1>604 Scaife Hall</ADDRESS_1>
<ADDRESS_2>3550 Terrace Street</ADDRESS_2>
<CITY>Pittsburgh</CITY>
<ZIP>15261</ZIP>
<REGION>Pennsylvania</REGION>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>412-647-8110</PHONE_1>
<PHONE_2/>
<FAX_1>412-647-3791</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7CF4938282E26AA201650CEABCFF18C5" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Matthew</FIRST_NAME>
<MIDDLE_INITIALS>R</MIDDLE_INITIALS>
<LAST_NAME>Rosengart</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>rosengartmr@upmc.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Surgery</DEPARTMENT>
<ORGANISATION>University of Pittsburgh</ORGANISATION>
<ADDRESS_1>F-1266.1, 200 Lothrop Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Pittsburgh</CITY>
<ZIP>PA 15213</ZIP>
<REGION/>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>+1 412 6470860</PHONE_1>
<PHONE_2/>
<FAX_1>+1 412 6471448</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2009-03-23 10:34:02 +0100" MODIFIED_BY="Gudrun Paletta">
<UP_TO_DATE>
<DATE DAY="31" MONTH="12" YEAR="2007"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="12" YEAR="2007"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="12" MONTH="8" YEAR="2010"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2009-03-23 11:08:49 +0100" MODIFIED_BY="Gudrun Paletta">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-03-23 11:08:49 +0100" MODIFIED_BY="Gudrun Paletta">
<DATE DAY="23" MONTH="3" YEAR="2009"/>
<DESCRIPTION>
<P>Subsections bug fixed</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>National Institutes of Health Grant IKIZ HD049109-01</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-08-13 23:27:36 +0200" MODIFIED_BY="Bernd Richter">
<SUMMARY MODIFIED="2008-08-13 10:01:43 +0200" MODIFIED_BY="Bernd Richter">
<TITLE MODIFIED="2008-08-06 12:20:03 +0200" MODIFIED_BY="[Empty name]">Parenteral calcium for intensive care unit patients</TITLE>
<SUMMARY_BODY MODIFIED="2008-08-13 10:01:43 +0200" MODIFIED_BY="Bernd Richter">
<P>Several epidemiological studies of critically ill patients highlight a direct association between low levels of calcium (hypocalcemia) and mortality, though whether this association is causal is unknown. On the other hand, despite prior studies detailing associations between hypocalcemia and poor outcome, there is evidence to suggest that calcium supplementation in critical illness may be deleterious. Five randomized controlled trials with 159 participants were detected. All of the five included studies were conducted in the USA. No trial evaluated the association between parenteral calcium supplementation in critically ill intensive care unit patients and the following outcomes: mortality, multiple organ dysfunction, intensive care unit and hospital length of stay, costs, and complications of calcium administration. Some data on laboratory measurements (serum calcium) could be extracted. Nonetheless, these data provide little to guide the care of intensive care unit patients. The question of greater importance, "Does correcting hypocalcemia in critically ill patients provide any benefit in reducing mortality, the development of organ dysfunction, or the allocation of resources ?" remains to be answered. At present, the evidence base for guidelines regarding calcium administration in intensive care unit patients is poor.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-08-13 12:32:49 +0200" MODIFIED_BY="Bernd Richter">
<ABS_BACKGROUND MODIFIED="2008-08-11 19:50:42 +0200" MODIFIED_BY="Bernd Richter">
<P>Hypocalcemia is prevalent among critically ill patients requiring intensive care. Several epidemiological studies highlight a direct association between hypocalcemia and mortality. These data provide the impetus for current guidelines recommending parenteral calcium administration to normalize serum calcium. However, in light of the considerable variation in the threshold for calcium replacement, the lack of evidence to support a causal role of hypocalcemia in mortality, and animal studies illustrating that calcium supplementation may worsen outcomes, a systematic review is essential to evaluate whether or not the practice of calcium supplementation for intensive care unit (ICU) patients provides any benefit.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2008-08-13 12:28:24 +0200" MODIFIED_BY="Bernd Richter">
<P>To assess the effects of parenteral calcium administration in ICU patients on the following outcomes: mortality, multiple organ dysfunction, ICU and hospital length of stay, costs, serum ionized calcium concentration, and complications of parenteral calcium administration.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-08-13 12:32:49 +0200" MODIFIED_BY="Bernd Richter">
<P>We searched <I>The Cochrane Library</I>, MEDLINE, EMBASE, Current Controlled Trials, and the National Research Register. We hand-searched conference abstracts from the Society of Critical Care Medicine, the European Society of Intensive Care Medicine, the American Thoracic Surgery, the American College of Surgeons, the American College of Chest Physicians, the American College of Physicians, and the International Consensus Conference in Intensive Care Medicine. We checked references of publications and attempted to contact authors to identify additional published or unpublished data.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-08-11 19:52:26 +0200" MODIFIED_BY="Bernd Richter">
<P>Randomised controlled and controlled clinical trials of ICU patients comparing parenteral calcium chloride or calcium gluconate administration with no treatment or placebo.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two reviewers independently applied eligibility criteria to trial reports for inclusion and extracted data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-08-13 12:32:04 +0200" MODIFIED_BY="Bernd Richter">
<P>There are no identifiable studies that have evaluated the association between parenteral calcium supplementation in critically ill ICU patients and the following outcomes: mortality, multiple organ dysfunction, ICU and hospital length of stay, costs, and complications of calcium administration. Serum ionized calcium concentration was reported in 5 studies (12 trial arms, 159 participants). These trials showed a small but significant increase in serum ionized calcium concentration after calcium administration. These trials showed considerable statistical heterogeneity and differed extensively in the population studied (adult versus neonate), the indication (hypocalcemia versus prophylaxis) and threshold of hypocalcemia for which parenteral calcium was administered, and the timing of subsequent measurement of serum ionized calcium concentration to the extent that we consider a pooled estimate almost inappropriate.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>There is no clear evidence that parenteral calcium supplementation impacts the outcome of critically ill patients. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-08-13 23:27:36 +0200" MODIFIED_BY="Bernd Richter">
<BACKGROUND MODIFIED="2008-08-13 23:27:36 +0200" MODIFIED_BY="Bernd Richter">
<CONDITION MODIFIED="2008-08-13 14:24:13 +0200" MODIFIED_BY="Bernd Richter">
<P>Hypocalcemia, as defined by a serum ionized calcium concentration ([Ca<SUP>2+</SUP>]i) less than 1.15 mmol/L, is prevalent in up to 88% of critically ill patients (<LINK REF="REF-Desai-1988" TYPE="REFERENCE">Desai 1988</LINK>; <LINK REF="REF-Zaloga-1987" TYPE="REFERENCE">Zaloga 1987</LINK>; <LINK REF="REF-Zivin-2001" TYPE="REFERENCE">Zivin 2001</LINK>). During homeostasis, [Ca<SUP>2+</SUP>]i is tightly regulated both systemically, as well as, at the cellular level so as to maintain vital cellular and organ physiology. Hypocalcemia has been associated with coagulopathy, neuromuscular excitability (e.g. tetany, laryngospasm), and cardiovascular complications (e.g. hypotension, decreased cardiac output, cardiac arrhythmias). Several epidemiological studies of critically ill patients highlight a direct association between hypocalcemia and mortality, though whether this association is causal is unknown (<LINK REF="REF-Hastbacka-2003" TYPE="REFERENCE">Hastbacka 2003</LINK>). The etiology of hypocalcemia during critical illness is unexplained, though most likely a multifactorial consequence of both cellular and hormonal dysfunction. Despite low systemic [Ca<SUP>2+</SUP>]i , intracellular [Ca<SUP>2+</SUP>]i is elevated in liver, aortic smooth muscle, myocardium, blood cells, and brain in experimental models of sepsis or septic patients, in models of ischemia/reperfusion, and in severely injured trauma patients (<LINK REF="REF-Meissner-1995" TYPE="REFERENCE">Meissner 1995</LINK>; <LINK REF="REF-Rose-1992" TYPE="REFERENCE">Rose 1992</LINK>; <LINK REF="REF-Sayeed-1986" TYPE="REFERENCE">Sayeed 1986</LINK>; <LINK REF="REF-Song-1993" TYPE="REFERENCE">Song 1993</LINK>; <LINK REF="REF-Sowemimo_x002d_Coker-1985" TYPE="REFERENCE">Sowemimo-Coker 1985</LINK>; <LINK REF="REF-Thompson-2000" TYPE="REFERENCE">Thompson 2000</LINK>; <LINK REF="REF-Zaloga-1993" TYPE="REFERENCE">Zaloga 1993</LINK>). Myocardial dysfunction consequent to sepsis, trauma or ischemia has been correlated with elevated intracellular [Ca<SUP>2+</SUP>]i (<LINK REF="REF-Horton-1999" TYPE="REFERENCE">Horton 1999</LINK>; <LINK REF="REF-Meissner-1995" TYPE="REFERENCE">Meissner 1995</LINK>; <LINK REF="REF-Thompson-2000" TYPE="REFERENCE">Thompson 2000</LINK>; <LINK REF="REF-White-2002" TYPE="REFERENCE">White 2002</LINK>). Similar dysfunction or cellular injury consequent to elevated cytosolic calcium concentration is observed in skeletal muscle (<LINK REF="REF-Hotchkiss-1994" TYPE="REFERENCE">Hotchkiss 1994</LINK>; <LINK REF="REF-Tomera-1992" TYPE="REFERENCE">Tomera 1992</LINK>), red blood cells (<LINK REF="REF-Fujita-1999" TYPE="REFERENCE">Fujita 1999</LINK>; <LINK REF="REF-Sowemimo_x002d_Coker-1985" TYPE="REFERENCE">Sowemimo-Coker 1985</LINK>) and the liver (<LINK REF="REF-Spitzer-1986" TYPE="REFERENCE">Spitzer 1986</LINK>). Impaired intracellular calcium handling, common to all these pathologic states, is often cited as the mediator of toxic cell death and subsequent organ dysfunction (<LINK REF="REF-Fekete-2001" TYPE="REFERENCE">Fekete 2001</LINK>; <LINK REF="REF-Hauser-2000" TYPE="REFERENCE">Hauser 2000</LINK>). It has been hypothesized that persistent elevation of intracellular calcium concentration sustains the septic response after the infection has been eliminated and leads to multiple organ dysfunction (MOD), and that hypocalcemia could in part be protective (<LINK REF="REF-Vincent-1995" TYPE="REFERENCE">Vincent 1995</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2008-08-13 14:14:29 +0200" MODIFIED_BY="Bernd Richter">
<P>Though population-based analyses have established similar thresholds for defining hypocalcemia ([Ca<SUP>2+</SUP>]i less than 1.15 mmol/L), consensus has never been achieved as to the [Ca<SUP>2+</SUP>]i threshold necessitating supplementation (0.65 mmol/L to 1.12 mmol/L). Nevertheless, because of the integral role of calcium in nearly every vital and cellular function, supplementation to normalize serum ionized calcium concentration [Ca<SUP>2+</SUP>]i is recommended (<LINK REF="REF-Aslam-2003" TYPE="REFERENCE">Aslam 2003</LINK>; <LINK REF="REF-Burchard-1990" TYPE="REFERENCE">Burchard 1990</LINK>; <LINK REF="REF-Forman-1991" TYPE="REFERENCE">Forman 1991</LINK>; <LINK REF="REF-Hammer-1998" TYPE="REFERENCE">Hammer 1998</LINK>; <LINK REF="REF-Marino-1998" TYPE="REFERENCE">Marino 1998</LINK>; <LINK REF="REF-Zivin-2001" TYPE="REFERENCE">Zivin 2001</LINK>). Replacement typically is achieved through parenteral supplementation with either calcium chloride or calcium gluconate, with administration guided by institutional or practitioner preference. Such therapy is thought to be essential in maintaining normal cellular and organ physiology, with emphasis upon calcium's function in cardiovascular and neuromuscular homeostasis.</P>
</INTERVENTION>
<THEORY MODIFIED="2008-08-13 23:27:36 +0200" MODIFIED_BY="Bernd Richter">
<P>Despite prior studies detailing associations between hypocalcemia and poor outcome, there is substantial evidence that calcium supplementation in critical illness may be deleterious and considerable molecular evidence of calcium's role in perpetuating aberrant inflammatory responses and inducing cell death. No study has determined that the association between hypocalcemia and either MOD or mortality is causal, and that this deviation from normality requires therapy (<LINK REF="REF-Carlon-1980" TYPE="REFERENCE">Carlon 1980</LINK>; <LINK REF="REF-Carlstedt-1998" TYPE="REFERENCE">Carlstedt 1998</LINK>; <LINK REF="REF-Carlstedt-2000" TYPE="REFERENCE">Carlstedt 2000</LINK>; <LINK REF="REF-Drop-1975" TYPE="REFERENCE">Drop 1975</LINK>; <LINK REF="REF-Venkataraman-1985" TYPE="REFERENCE">Venkataraman 1985</LINK>). Human studies in both sepsis and trauma note no improvement in outcome with calcium supplementation (<LINK REF="REF-Carlon-1980" TYPE="REFERENCE">Carlon 1980</LINK>). Several animal models of sepsis and trauma document worsened mortality and organ dysfunction with calcium replacement, (<LINK REF="REF-Carlstedt-2000" TYPE="REFERENCE">Carlstedt 2000</LINK>; <LINK REF="REF-Hotchkiss-1996" TYPE="REFERENCE">Hotchkiss 1996</LINK>; <LINK REF="REF-Malcolm-1989" TYPE="REFERENCE">Malcolm 1989</LINK>; <LINK REF="REF-Zaloga-1992" TYPE="REFERENCE">Zaloga 1992</LINK>) and others report improvement with calcium antagonism (<LINK REF="REF-Bosson-1985" TYPE="REFERENCE">Bosson 1985</LINK>; <LINK REF="REF-Carlstedt-2000" TYPE="REFERENCE">Carlstedt 2000</LINK>; <LINK REF="REF-Lee-1986" TYPE="REFERENCE">Lee 1986</LINK>). Clinical trials of calcium supplementation during cardiopulmonary bypass or sepsis document no improvement in myocardial function and increased myocardial workload with supplementation, (<LINK REF="REF-Porter-1983" TYPE="REFERENCE">Porter 1983</LINK>; <LINK REF="REF-Royster-1992" TYPE="REFERENCE">Royster 1992</LINK>; <LINK REF="REF-Vincent-1995" TYPE="REFERENCE">Vincent 1995</LINK>; <LINK REF="REF-Zaloga-1992" TYPE="REFERENCE">Zaloga 1992</LINK>) whereas reducing calcium overload improved contractility (<LINK REF="REF-Hugtenburg-1990" TYPE="REFERENCE">Hugtenburg 1990</LINK>; <LINK REF="REF-Horton-1999" TYPE="REFERENCE">Horton 1999</LINK>; <LINK REF="REF-Tanonaka-1999" TYPE="REFERENCE">Tanonaka 1999</LINK>; <LINK REF="REF-White-2002" TYPE="REFERENCE">White 2002</LINK>). Reductions in cellular dysfunction and injury in models of sepsis have been achieved by maintaining low extracellular calcium concentrations or administering calcium antagonists (<LINK REF="REF-Deakin-1991" TYPE="REFERENCE">Deakin 1991</LINK>; <LINK REF="REF-Sayeed-1986" TYPE="REFERENCE">Sayeed 1986</LINK>; <LINK REF="REF-Sayeed-2000" TYPE="REFERENCE">Sayeed 2000</LINK>). </P>
<SUBSECTION>
<HEADING LEVEL="3">Adverse effects of the intervention</HEADING>
<P>In light of the considerable variation in the threshold for calcium replacement, the lack of support for a causal role of hypocalcemia in mortality, and the substantial evidence illustrating calcium supplementation does little to improve, and may in fact worsen, organ dysfunction and mortality, a systematic review is essential to evaluate whether the practice of calcium supplementation for intensive care unit patients provides any benefit.</P>
</SUBSECTION>
</THEORY>
<IMPORTANCE MODIFIED="2008-08-13 12:52:39 +0200" MODIFIED_BY="Bernd Richter">
<P>No prior systematic review has been conducted to ascertain whether the evidence supports our current practice patterns of managing hypocalcemia in critically ill patients. Prior tenets of critical care medicine, such as normalizing tidal volumes to treat hypoxemia (<LINK REF="REF-ARDS-Network-2000" TYPE="REFERENCE">ARDS Network 2000</LINK>) and normalizing protein anabolism by administering growth hormone (<LINK REF="REF-Takala-1999" TYPE="REFERENCE">Takala 1999</LINK>) were definitively demonstrated to increase the risk of death when subjected to the rigors of randomized, controlled trials. In the context of this current evidence, our perspective of hypocalcemia of critical illness and practice patterns of managing hypocalcemia necessitate the same rigorous evaluation that enlightened us to the dangers posed by these earlier axioms of medicine.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P>To assess the effects of parenteral calcium administration in intensive care unit (ICU) patients.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-08-13 12:54:08 +0200" MODIFIED_BY="Bernd Richter">
<SELECTION_CRITERIA MODIFIED="2008-08-11 20:12:02 +0200" MODIFIED_BY="Bernd Richter">
<CRIT_STUDIES MODIFIED="2008-08-11 19:59:01 +0200" MODIFIED_BY="Bernd Richter">
<P>We planned to include randomized controlled clinical trials (RCTs) and controlled clinical trials (CCTs).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-08-11 20:12:02 +0200" MODIFIED_BY="Bernd Richter">
<P>Participants had to be ICU patients, regardless of gender and age, who are critically ill as defined by admission to an ICU.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-08-11 20:00:21 +0200" MODIFIED_BY="Bernd Richter">
<UL>
<LI>parenteral calcium supplementation (calcium gluconate or calcium chloride) versus no treatment;</LI>
<LI>parenteral calcium supplementation (calcium gluconate or calcium chloride) versus placebo.</LI>
</UL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-08-11 20:02:08 +0200" MODIFIED_BY="Bernd Richter">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-08-11 20:00:39 +0200" MODIFIED_BY="Bernd Richter">
<UL>
<LI>mortality;</LI>
<LI>organ dysfunction as defined by the sequential organ failure assessment (SOFA) score.</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-08-11 20:02:08 +0200" MODIFIED_BY="Bernd Richter">
<UL>
<LI>ICU length of stay;</LI>
<LI>hospital length of stay;</LI>
<LI>costs;</LI>
<LI>adverse effects;</LI>
<LI>ionized calcium concentration.</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="5">Possible covariates, confounders, effect modifiers</HEADING>
<UL>
<LI>admission diagnosis (sepsis, trauma, premature birth, or other);</LI>
<LI>presence of a calcium concentration-guided supplementation protocol;</LI>
<LI>threshold of hypocalcemia.</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-08-13 10:15:27 +0200" MODIFIED_BY="Bernd Richter">
<ELECTRONIC_SEARCHES MODIFIED="2008-08-13 10:15:27 +0200" MODIFIED_BY="Bernd Richter">
<P>The search strategy was conducted independently by RMF and MRR and included the following:</P>
<UL>
<LI>The <I>Cochrane Library</I> (issue 4, 2007);</LI>
<LI>MEDLINE (until December 31, 2005);</LI>
<LI>EMBASE (until December 31, 2005).</LI>
</UL>
<P>
<BR/>We also searched databases of ongoing trials: 'Current Controlled Trials' (www.controlled-trials.com - with links to other databases of ongoing trials).</P>
<P>For detailed search strategies please see under <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2008-08-12 12:25:24 +0200" MODIFIED_BY="Bernd Richter">
<P>Conference abstracts from the meetings of the Society of Critical Care Medicine (from 2000), the European Society of Intensive Care Medicine (from 2000), American Thoracic Surgery (from 2000), the American College of Surgeons (from 2000), the American College of Chest Physicians (from 2000), the American College of Physicians (from 2000), and the International Consensus Conference in Intensive Care Medicine (from 2000).</P>
<P>We tried to identify additional studies by searching the reference list of relevant trials and reviews identified. Authors of relevant identified studies and other experts were planned to be contacted in order to obtain additional references, unpublished trials, or ongoing trials. The Cochrane Metabolic and Endocrine Disorders Group was contacted to check whether they are aware of any studies not identified by the search strategy.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-08-13 12:54:08 +0200" MODIFIED_BY="Bernd Richter">
<STUDY_SELECTION MODIFIED="2008-08-13 12:53:38 +0200" MODIFIED_BY="Bernd Richter">
<P>RMF and MRR separately assessed the titles and abstracts from identified trials to determine whether they met the inclusion criteria. Interrater agreement for study selection were measured using the kappa statistic (<LINK REF="REF-Cohen-1960" TYPE="REFERENCE">Cohen 1960</LINK>). Where differences in opinion existed, they were resolved by a third party (DCA). If resolving disagreement was not possible, the article was added to those 'awaiting assessment' and the authors were planned to be contacted for clarification. If no clarification could be provided, the review group editorial base was planned to be consulted.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2008-08-11 20:16:00 +0200" MODIFIED_BY="Bernd Richter">
<P>Data were extracted independently by RMF and MRR, and any discrepancies were resolved by discussion. If any doubt on eligibility persisted, we assessed the full article to determine whether the trial conformed to the inclusion criteria.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2008-08-12 11:37:01 +0200" MODIFIED_BY="Bernd Richter">
<P>Quality assessment was planned to be performed separately by RMF and MRR. We have developed quality assessment instruments that incorporate aspects specific to RCTs and CCTs, as well as, aspects particular to this protocol of calcium supplementation.</P>
<P>We wanted to assess the quality of reporting of each trial utilizing the quality criteria specified by Schulz and Jadad (<LINK REF="REF-Jadad-1996" TYPE="REFERENCE">Jadad 1996</LINK>; <LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>).<BR/>Specifically, the following factors were planned to be studied:<BR/>(1) minimization of selection bias - a) was the randomization procedure adequate? b) was the allocation concealment adequate?<BR/>(2) minimization of performance bias - were the patients and people administering the treatment blind to the intervention?<BR/>(3) minimization of attrition bias - a) were withdrawals and dropouts completely described? b) was analysis by intention-to-treat?<BR/>(4) minimization of detection bias - were outcome assessors blind to the intervention?</P>
<P>These questions were to be answered as yes, no, or unclear. Clarification from the primary author was planned to be sought if the published data provided inadequate information for the review.</P>
<P>Based on these criteria, studies were planned to be broadly subdivided into the following three categories:<BR/>A - all quality criteria met: low risk of bias<BR/>B - one or more of the quality criteria only partly met: moderate risk of bias<BR/>C - one or more criteria not met: high risk of bias.</P>
<P>This classification was planned to be used as the basis of a sensitivity analysis.</P>
<P>We wanted to explore the influence of individual quality criteria, the statistical model, and publication status in a series of sensitivity analyses. Interrater agreement was planned to be calculated using the kappa statistic on allocation concealment.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2008-08-12 11:38:14 +0200" MODIFIED_BY="Bernd Richter">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>Dichotomous data were analyzed using the Mantel Haenzel method, and the outcomes were reported as relative risk (RR) and risk difference (RD) with 95% confidence intervals (CI).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>Continuous data were analyzed using an inverse variance model of weighted mean differences, and the outcomes were reported as mean difference with 95% CI.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Time-to-event data</HEADING>
<P>Kaplan Meier analyses were planned to be performed to estimate rates of mortality and ICU and hospital lengths of stay according to study group (calcium supplementation vs. control), and the differences in those rates between the two groups were planned to be analyzed with the log-rank test.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2008-08-12 11:46:27 +0200" MODIFIED_BY="Bernd Richter">
<P>Ionized calcium concentration ([Ca<SUP>2+</SUP>]i) was standardized across all trials by conversion to mmol/L.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2008-08-12 11:39:06 +0200" MODIFIED_BY="Bernd Richter">
<P>Authors were planned to be contacted for missing data or clarification.</P>
<SUBSECTION>
<HEADING LEVEL="4">Dealing with duplicate publications</HEADING>
<P>In the case of duplicate publications and companion papers of a primary study, we wanted to maximise yield of information by simultaneous evaluation of all available data. In cases of doubt, the original publication (usually the oldest version) would have obtained priority.</P>
</SUBSECTION>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2008-08-12 11:39:33 +0200" MODIFIED_BY="Bernd Richter">
<P>Heterogeneity was analyzed using the Chi-squared test, with an a of 0.1 used for statistical significance. Heterogeneity will also be examined with I<SUP>2</SUP>, where I<SUP>2 </SUP>values of 50% and more indicate a substantial level of heterogeneity (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). When heterogeneity was found, we attempted to determine potential reasons for it by examining individual study characteristics and those of subgroups of the main body of evidence.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2008-08-12 11:39:58 +0200" MODIFIED_BY="Bernd Richter">
<P>Analysis for possible small study bias was planned to be attempted using funnel plot (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>).</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2008-08-13 12:54:08 +0200" MODIFIED_BY="Bernd Richter">
<P>Data were pooled using the random effects model, but the fixed effect model was also analyzed to ensure robustness of the model chosen and susceptibility to outliers.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2008-08-12 11:41:11 +0200" MODIFIED_BY="Bernd Richter">
<P>Subgroup analyses were planned to only be performed if one of the primary outcome parameters demonstrated statistically significant differences between treatment groups. The following subgroup analyses were planned:<BR/>
</P>
<UL>
<LI>admission diagnosis;</LI>
<LI>calcium concentration-guided supplementation protocol;</LI>
<LI>age.</LI>
</UL>
<P>
<BR/>Further data identified that may explain the recorded patterns were planned to be used as hypothesis generators.<BR/>
</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2008-08-12 11:41:37 +0200" MODIFIED_BY="Bernd Richter">
<P>We wanted to perform sensitivity analyses in order to explore the influence of the following factors on effect size:</P>
<UL>
<LI>repeating the analysis excluding unpublished studies;</LI>
<LI>repeating the analysis taking account of study quality, as specified above;</LI>
<LI>repeating the analysis excluding any very long or large studies to establish how much they dominate the results;</LI>
<LI>repeating the analysis excluding studies using the following filters: diagnostic criteria, language of publication, source of funding (industry versus other), and country.</LI>
</UL>
<P>The robustness of the results was also planned to be tested by repeating the analysis using different measures of effects size (risk difference, odds ratio etc.) and different statistic models (fixed and random effects models).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-08-13 12:54:43 +0200" MODIFIED_BY="Bernd Richter">
<STUDY_DESCRIPTION MODIFIED="2008-08-12 12:30:30 +0200" MODIFIED_BY="Bernd Richter">
<SEARCH_RESULTS MODIFIED="2008-08-12 11:45:07 +0200" MODIFIED_BY="Bernd Richter">
<P>The search strategy generated 11,626 hits. Screening of titles and abstracts identified 28 papers for formal inclusion or exclusion. Of these 23 were excluded and 5 trials met the inclusion criteria.</P>
<P>Details of the studies included in the review are shown under <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. Reasons for exclusion for the majority of studies included the following criteria: 1) the cohort was not intensive care unit (ICU) patients; 2) the control group did not receive placebo or no therapy. Details and reasons for the exclusion for the studies which most closely missed the strict inclusion criteria are presented under <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2008-08-12 12:30:30 +0200" MODIFIED_BY="Bernd Richter">
<P>Details of methods, participants, interventions and outcome measures are presented in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. Five trials with 7 arms were included with 159 participants randomized. All of the 5 included trials were conducted in the USA.</P>
<SUBSECTION>
<HEADING LEVEL="4">Mortality</HEADING>
<P>No trial included information on mortality.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Multiple organ dysfunction</HEADING>
<P>No trial included information on multiple organ dysfunction.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Length of stay</HEADING>
<P>No trial included information on ICU or hospital length of stay.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Costs</HEADING>
<P>No trial included information on costs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Complications</HEADING>
<P>No trial included information on complications from calcium administration.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Calcium concentration</HEADING>
<P>Five trials included information on ionized calcium concentration ([Ca<SUP>2+</SUP>]i).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-08-12 11:34:42 +0200" MODIFIED_BY="Bernd Richter">
<ALLOCATION MODIFIED="2008-08-06 12:35:49 +0200" MODIFIED_BY="[Empty name]">
<P>In general, details of the methods utilised in the included studies in this review were poorly reported.</P>
<P>Methods of allocation concealment were poorly described.</P>
<P>
<B>Randomisation</B>
<BR/>All trials involved randomisation, but the methods were poorly described.</P>
</ALLOCATION>
<BLINDING MODIFIED="2008-08-06 12:33:53 +0200" MODIFIED_BY="[Empty name]">
<P>Methods of blinding were poorly described.</P>
</BLINDING>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-08-13 12:54:43 +0200" MODIFIED_BY="Bernd Richter">
<SUBSECTION>
<HEADING LEVEL="3">Mortality, organ dysfunction, ICU and hospital length of stay, complications</HEADING>
<P>There are no identifiable studies that have evaluated the association between parenteral calcium supplementation in critically ill ICU patients and the following outcomes: mortality, multiple organ dysfunction, ICU and hospital length of stay, costs, and complications of calcium administration.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Ionized calcium concentration</HEADING>
<P>Serum [Ca<SUP>2+</SUP>]i was reported in five studies (11 trial arms, 159 participants). Three trials studied adult patients undergoing elective cardiopulmonary bypass surgery, and the remaining two trials involved neonates with hypocalcemia. All trials administered parenteral administration as either calcium chloride or calcium gluconate. Three trials, including the two neonatal trials, administered calcium after the documentation of hypocalcemia (<LINK REF="STD-Auffant-1981" TYPE="STUDY">Auffant 1981</LINK>; <LINK REF="STD-Porcelli-1995" TYPE="STUDY">Porcelli 1995</LINK>; <LINK REF="STD-Scott-1984" TYPE="STUDY">Scott 1984</LINK>). Two trials evaluated both bolus and continuous calcium infusion (<LINK REF="STD-Auffant-1981" TYPE="STUDY">Auffant 1981</LINK>; <LINK REF="STD-Scott-1984" TYPE="STUDY">Scott 1984</LINK>).</P>
<P>We observed considerable statistical heterogeneity in the included trials making any summary estimate, in our opinion, inappropriate. Our qualitative assessment of the combinability of these trials reached similar conclusions. These trials differed extensively in the population studied (adult versus neonate), the indication (hypocalcemia versus prophylaxis) and threshold of hypocalcemia for which parenteral calcium was administered, the methods of calcium administration (bolus versus infusion), and the timing of subsequent measurement of serum [Ca<SUP>2+</SUP>]i (early, less than 30 minutes; late, 3 to 6 hours) to the extent that we consider a pooled estimate almost inappropriate. However, we have attempted to combine trials, similar in the aforementioned characteristics, to provide some summary estimate of the effects of calcium supplementation on serum [Ca<SUP>2+</SUP>]i.</P>
<SUBSECTION>
<HEADING LEVEL="4">Calcium Infusion</HEADING>
<P>There was a small but significant increase in serum [Ca<SUP>2+</SUP>]i when measured early (less than 30 minutes) (difference in means 0.24 mmol/L, 95% confidence interval (CI) 0.00 to 0.49), that was not maintained late (3 to 6 hours) (difference in means 0.12 mmol/L, 95% CI -0.02 to 0.26) following calcium infusion. These three trials of early assessment after infusion (<LINK REF="STD-Auffant-1981" TYPE="STUDY">Auffant 1981</LINK>; <LINK REF="STD-Butterworth-1992" TYPE="STUDY">Butterworth 1992</LINK>; <LINK REF="STD-Zaloga-1990" TYPE="STUDY">Zaloga 1990</LINK>) were the adult trials undergoing elective cardiac operations. We observed considerable statistical heterogeneity, as the I<SUP>2</SUP> exceeded 50% in both analyses, which we attribute to the variability in indication for calcium supplementation (i.e. hypocalcemia versus prophylaxis).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Calcium bolus</HEADING>
<P>Only one trial (<LINK REF="STD-Auffant-1981" TYPE="STUDY">Auffant 1981</LINK>) assessed [Ca<SUP>2+</SUP>]i early after bolus administration and showed a significant increase in [Ca<SUP>2+</SUP>]i (difference in means 0.08 mmol/L, 95% CI 0.05 to 0.11). This trial and one other (<LINK REF="STD-Scott-1984" TYPE="STUDY">Scott 1984</LINK>) assessed serum [Ca<SUP>2+</SUP>]i late after bolus administration and did not detect a significant increase (difference in means 0.05 mmol/L, 95% CI -0.01 to 0.12).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Studies in neonates</HEADING>
<P>Two trials of neonatal hypocalcemia observed an increase in serum [Ca<SUP>2+</SUP>]i (difference in means 0.06 mmol/L, 95% CI 0.01 to 0.11) with parenteral calcium administration.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-08-13 14:37:48 +0200" MODIFIED_BY="Bernd Richter">
<P>We did not identify any study which evaluated the association between parenteral calcium supplementation and the clinical outcomes of mortality, multiple organ dysfunction, intensive care unit (ICU) and hospital lengths of stay, costs, or complications of calcium administration in critically ill ICU patients. We conducted a very thorough literature search, where over 11,000 citations were screened to identify eligible trials. We believe it unlikely that relevant trials have been overlooked.</P>
<P>Five trials met the inclusion criteria and monitored ionized calcium concentration ([Ca<SUP>2+</SUP>]i) subsequent to calcium supplementation. In general, the combined data of these trials showed that parenteral calcium administration increases systemic [Ca<SUP>2+</SUP>]i early after calcium administration. However, these trials were distinct, differing extensively in the population studied (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>), the indication and threshold of hypocalcemia for which calcium was administered, and the timing and duration of subsequent measurement of calcium concentration (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>) to the extent that we consider a pooled estimate almost inappropriate. Pertinent to this last concern, we defined time points of serum [Ca<SUP>2+</SUP>]i measurement after supplementation (early, less than 30 minutes; late, 3 to 6 hours) in an effort to provide some summary estimates. Calcium infusion increased, though did not maintain, elevated systemic [Ca<SUP>2+</SUP>]i by comparison to placebo control. Two of these trials (<LINK REF="STD-Butterworth-1992" TYPE="STUDY">Butterworth 1992</LINK>; <LINK REF="STD-Zaloga-1990" TYPE="STUDY">Zaloga 1990</LINK>) did not predicate calcium supplementation upon the diagnosis of hypocalcemia, and considerable statistical heterogeneity was observed. However, these characteristics did not appear to bias the estimate away from showing a difference. Similarly, the elevated [Ca<SUP>2+</SUP>]i early after bolus administration was not maintained, although the paucity of trials prohibits any definitive conclusion. The two neonatal trials (<LINK REF="STD-Porcelli-1995" TYPE="STUDY">Porcelli 1995</LINK>; <LINK REF="STD-Scott-1984" TYPE="STUDY">Scott 1984</LINK>), which did define a hypocalcemia threshold for calcium supplementation, observed increased [Ca<SUP>2+</SUP>]i with supplementation; though, this estimate is primarily based upon one trial (<LINK REF="STD-Porcelli-1995" TYPE="STUDY">Porcelli 1995</LINK>). Nonetheless, these data provide little to guide the care of ICU patients. The question of greater importance, "Does correcting hypocalcemia in critically ill patients provide any benefit in reducing mortality, the development of organ dysfunction, or the allocation of resources (i.e. ICU and hospital length of stay, costs)?" remains to be answered.</P>
<P>Many trials identified for formal inclusion or exclusion evaluated the influence of [Ca<SUP>2+</SUP>]i among patients undergoing operative cardiac procedures requiring cardiopulmonary bypass. These trials assessed the benefits of parenteral calcium administration in facilitating emergence from cardiopulmonary bypass and typically measured a cadre of hemodynamic parameters (i.e. cardiac output, left and right ventricular function, systemic vascular resistance, pulmonary vascular resistance). The considerable variability in these trials precludes summarizing the results. Nonetheless, in general, the following observations were noted for cohorts receiving calcium supplementation by contrast to their control counterparts: 1) increased mean arterial pressure; 2) no improvement in ventricular function; 3) no improvement in separation from cardiopulmonary bypass. Although these results support the concept that calcium supplementation is not of benefit, they were excluded because they failed to fulfill the pre-set criteria. Hence, the current body of evidence still wants for an evaluation of the ramifications of calcium supplementation on the more clinically relevant outcomes we proposed.</P>
<P>At present, the evidence base for guidelines regarding calcium administration in ICU patients is poor. This is not entirely unexpected. Much of the impetus to recommend normalizing serum [Ca<SUP>2+</SUP>]i stems from observational studies demonstrating an association between hypocalcemia and mortality. Cellular and physiological studies emphasize the importance of calcium homeostasis in normal cell function and organ physiology. Hence, the typical conclusion drawn is that hypocalcemia necessitates correction with calcium administration. However, opponents of such practice highlight animal studies noting increased mortality with calcium supplementation, hypothesizing that the development of hypocalcemia may provide a teleological survival mechanism. The combined evidence supports a reappraisal of our current perspective and practices of calcium supplementation in critical illness.</P>
<P>This review emphasizes the need to conduct well designed interventional trials to establish the impact of calcium supplementation on hypocalcemia of critical illness. It is possible that there may be studies of calcium supplementation, which have examined outcomes falling outside our inclusion criteria. And, as with all systematic reviews it is worth emphasizing that no evidence for effect, which is what we have found here, is not the same as evidence of no effect. Nevertheless, we believe that our review is comprehensive and highlights the lack of evidence on which to base current practices of administering calcium in the setting of hypocalcemia of critical illness. A number of factors need to be taken into account in planning evaluative and comparative research in the effects of calcium supplementation in ICU patients in effecting mortality and the development of organ dysfunction. These include the threshold of hypocalcemia for supplementation, the threshold of physiological derangement for calcium administration, the dose and rate of calcium administration, the timing of subsequent [Ca<SUP>2+</SUP>]i measurements and monitoring, the etiology of hypocalcemia (i.e. sepsis, trauma-related blood transfusion), and the duration and extent to which [Ca<SUP>2+</SUP>]i is measured and intervention applied. It is unlikely that any single conventional RCT would be able to address each of these issues.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-08-12 12:18:48 +0200" MODIFIED_BY="Bernd Richter">
<IMPLICATIONS_PRACTICE MODIFIED="2008-08-12 12:18:00 +0200" MODIFIED_BY="Bernd Richter">
<P>There is no clear evidence that calcium supplementation impacts the outcome of critically ill ICU patients, with the exception of elevating systemic [Ca<SUP>2+</SUP>]i. Future research should concentrate on the evaluation of calcium supplementation in critically ill ICU patients in association with the clinically relevant outcomes of mortality, multiple organ dysfunction, and allocation of resources (i.e. intensive care unit and hospital length of stay, costs).</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-08-12 12:18:48 +0200" MODIFIED_BY="Bernd Richter">
<P>There is a paucity of evidence on the benefit of calcium supplementation in critical illness. There are no trials of critically ill intensive care unit patients that have evaluated the effects of normalizing systemic ionized calcium concentration by parenteral administration of calcium on the outcomes of mortality and multiple organ dysfunction. A randomized, placebo-controlled trial of calcium supplementation in critical illness, preferably stratified by etiology of hypocalcemia, is best suited to answer this question. In view of the wide acceptance of calcium supplementation to treat hypocalcemia of critical illness, it may be difficult to conduct a placebo-controlled trial.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We are grateful to the Cochrane Metabolic and Endocrine Disorders Group for their technical support. </P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-08-13 10:40:12 +0200" MODIFIED_BY="Bernd Richter">
<P>Matthew Rosengart conducted the searches, selection of studies, data extraction, drafting and co-drafting the protocol and review, conducted the statistical analysis and data presentation, and the preparation of the manuscript.</P>
<P>Raquel Forsythe conducted the searches, selection of studies, data extraction, drafting and co-drafting the protocol and review, and conducted the statistical analysis and data presentation, and the preparation of the manuscript.</P>
<P>Timothy Billiar conducted the drafting and co-drafting of the protocol and review, assisted with the statistical analysis and data presentation, and the preparation of the manuscript.</P>
<P>Derek Angus assisted with drafting and co-drafting the protocol and review, conducting the statistical analysis and data presentation, and the preparation of the manuscript.</P>
<P>Charles Wessel assisted with conducting the searches, data extraction, drafting the review, and the preparation of the manuscript.</P>
<P>
<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-08-13 14:28:17 +0200" MODIFIED_BY="Bernd Richter">
<STUDIES MODIFIED="2008-08-13 10:53:09 +0200" MODIFIED_BY="Bernd Richter">
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Auffant-1981" NAME="Auffant 1981" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Auffant RA, Downs JB, Amick R</AU>
<TI>Ionized calcium concentration and cardiovascular function after cardiopulmonary bypass</TI>
<SO>Archives of Surgery</SO>
<YR>1981</YR>
<VL>116</VL>
<PG>1072-1076</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Butterworth-1992" NAME="Butterworth 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Butterworth JF, Zaloga GP, Prielipp RC, Tucker WY, Royster RL</AU>
<TI>Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone</TI>
<SO>Chest</SO>
<YR>1992</YR>
<VL>101</VL>
<NO>1</NO>
<PG>174-180</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Porcelli-1995" NAME="Porcelli 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Porcelli PJ, Oh W</AU>
<TI>Effects of single dose calcium gluconate infusion in hypocalcemia preterm infants</TI>
<SO>American Journal of Perinatology</SO>
<YR>1995</YR>
<VL>12</VL>
<NO>1</NO>
<PG>18-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scott-1984" NAME="Scott 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scott SM, Ladenson JH, Aguanna JJ, Walgate J, Hillman LS</AU>
<TI>Effect of calcium therapy in the sick premature infant with early neonatal hypocalcemia</TI>
<SO>The Journal of Pediatrics</SO>
<YR>1984</YR>
<VL>104</VL>
<NO>5</NO>
<PG>747-751</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zaloga-1990" NAME="Zaloga 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zaloga GP, Strickland RA, Butterworth JF, Mark LJ, Mills SA, Lake CR</AU>
<TI>Calcium attenuates epinephrine's Beta-adrenergic effects in postoperative heart surgery patients</TI>
<SO>Circulation</SO>
<YR>1990</YR>
<VL>81</VL>
<NO>1</NO>
<PG>196-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-08-13 10:53:09 +0200" MODIFIED_BY="Bernd Richter">
<STUDY DATA_SOURCE="PUB" ID="STD-Broner-1990" NAME="Broner 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;All patients received calcium&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cynthia W. Broner, Gergory L. Stidham, David F. Westenkirchner, Donald C. Watson</AU>
<TI>A prospective, randomized, double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children</TI>
<SO>The Journal of Pediatrics</SO>
<YR>1990</YR>
<VL>117</VL>
<NO>6</NO>
<PG>986-989</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Castillo-1991" NAME="Castillo 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not ICU patients&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carlos Ferna'ndez-Del Castillo, Wolfgang Harringer, Andres L. Warshaw, Gus J. Vlahakes, Greg Koski, Alan M. Zaslavsky, David W. Rattner</AU>
<TI>Risk factors for pancreatic cellular injury after cardiopulmonary bypass</TI>
<SO>The New England Journal of Medicine</SO>
<YR>1991</YR>
<VL>325</VL>
<NO>6</NO>
<PG>382-387</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cote_x0027_-1987" NAME="Cote' 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;No placebo control. All patients received calcium&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Charles J. Cote', Lambertus J. Drop, Alfred L. Daniels, David C. Hoaglin</AU>
<TI>Calcium chloride versus calcium gluconate: comparison of ionization and cardiovascular effects in children and dogs</TI>
<SO>Anesthesiology</SO>
<YR>1987</YR>
<VL>66</VL>
<PG>465-470</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cote_x0027_-1988" NAME="Cote' 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;No placebo. All patients received calcium&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Charles J. Cote', Lambertus J. Drop, David C. Hoaglin, Alfred L. Daniels, Elizabeth T. Young</AU>
<TI>Ionized hypocalcemia after fresh frozen plasma administration to thermally injured children</TI>
<SO>Anesthesia Analgesia</SO>
<YR>1988</YR>
<VL>67</VL>
<PG>152-160</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-d_x0027_Hollander" NAME="d'Hollander" YEAR="1982">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not a RCT or CCT&lt;br&gt;Not ICU patients: post-CPB&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alain d'Hollander, Gerogeas Primo, Dani`ele Hennart, Jean Louis Le Clerc, Frank E. Deuvaert, Jacqueline Dubois-Primo</AU>
<TI>Compared efficacy of dobutamine and dopamine in association with calcium chloride on termination of cardiopulmonary bypass</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1982</YR>
<VL>83</VL>
<NO>2</NO>
<PG>264-271</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Diaz-1994" NAME="Diaz 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>J. Diaz, F. Acosta, P. martinez, P. Parrilla</AU>
<TI>Treatment of ionic hypocalcemia during hepatic transplantation</TI>
<TO>Tratamiento de la hipocalcemia Ionica durante el transplante hepatico</TO>
<SO>Medicina Clinica</SO>
<YR>1994</YR>
<VL>103</VL>
<NO>3</NO>
<PG>118-119</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Drop-1980" NAME="Drop 1980" YEAR="1980">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not a RCT or CCT&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lambertus J. Drop, David J. Cullen</AU>
<TI>Comparative effects of calcium chloride adn calcium gluceptate</TI>
<SO>British Journal of Anesthaesia</SO>
<YR>1980</YR>
<VL>52</VL>
<PG>501-5-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ekery-2003" NAME="Ekery 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ekery DL, Davidoff R, Orlandi QG, Apstein CS, Hesselvik JF, Shemin RJ, Shapira OM.</AU>
<TI>Diastolic dysfunction after coronary artery bypass grafting: a frequent finding of clinical significance not influenced by intravenous calcium</TI>
<SO>American Heart Journal</SO>
<YR>2003</YR>
<VL>145</VL>
<NO>5</NO>
<PG>896-902</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gallagher-1984" NAME="Gallagher 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not ICU patients: pre- and post-intubation&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>John D. Gallagher, Edmund A. Geller, Roger A. Moor, Samir B. Botros, Arachelle B. Jose, Donald L. Clark</AU>
<TI>Hemodynamic effects of calcium chloride in adults with regurgitant valve lesions</TI>
<SO>Anesthesia Analgesia</SO>
<YR>2984</YR>
<VL>63</VL>
<PG>723-728</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guideri-1994" NAME="Guideri 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not a RCT or CCT: all patients received calcium&lt;br&gt;Not ICU patients: stable patients&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>F. Guideri, D. Ferber, G. Galgano, C. Frigerio, L. De Giorgi, F. Laghi Pasini, T. Di Perri</AU>
<TI>Calcium infusion induces myocardial ischaemis in patients with coronary artery disease by a mechanism possibly adenosine mediated</TI>
<SO>European Heart Journal</SO>
<YR>1994</YR>
<VL>15</VL>
<PG>1158-1163</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnston-1992" NAME="Johnston 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not on ICU patients: OR patients followed for 6 minutes after calcium.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnston WE, Robertie PG, Butterworth JF, Royster RL, Kon ND</AU>
<TI>Is calcium or ephedrine superior to placebo for emergence from cardiopulmonary bypass</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>1992</YR>
<VL>6</VL>
<NO>5</NO>
<PG>528-534</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kramer-2003" NAME="Kramer 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;No control. All patients received calcium.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ludwig Kramer, Edith Bauer, Christian Joukhadar, Wolfram Strobl, Alexandra Gendo, Christian Madl, Alfred Gangl</AU>
<TI>Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients</TI>
<SO>Critical Care Medicine</SO>
<YR>2003</YR>
<VL>31</VL>
<NO>10</NO>
<PG>2450-2455</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lijima-2005" NAME="Lijima 2005" YEAR="2005">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not an RCT or CCT: all patients received calcium&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shigeo Lijima, Naoki Uga, Yasuhiro Kawase, Hiroshi Tada</AU>
<TI>Prophylactic calcium administration for hyperkalemia in extremely low birthweight infants</TI>
<SO>American Journal of Perinatology</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>4</NO>
<PG>211-216</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martin-1990" NAME="Martin 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not a RCT or CCT: all received calcium&lt;br&gt;Not ICU patients: OR patients&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thomas J. Martin, Yoogoo Kang, Kerri M. Robertson, Mohamed A. Virji, Jose M. Marquez</AU>
<TI>Ionization and hemodynamic effects of calcium chloride and calcium gluconate in the absence of hepatic function</TI>
<SO>Anesthesiology</SO>
<YR>1990</YR>
<VL>73</VL>
<NO>1</NO>
<PG>62-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meliones-1991" MODIFIED="2008-08-13 10:51:31 +0200" MODIFIED_BY="Bernd Richter" NAME="Meliones 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-08-13 10:51:31 +0200" MODIFIED_BY="Bernd Richter" NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not a RCT or CCT: no control.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 10:51:31 +0200" NOTES_MODIFIED_BY="Bernd Richter" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jon N. Meliones, Frank W. Moler, Joseph R. Custer, Susan J. Snyder, Mary K. Dekeon, Steven M. Donn, Robin A. Chapman, Robert H. Bartlett</AU>
<TI>Hemodynamic instability after the initiation of extracorporeal membrane oxygenation: role of ionized calcium</TI>
<SO>Critical Care Medicine</SO>
<YR>1991</YR>
<VL>19</VL>
<NO>10</NO>
<PG>1247-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meliones-1995" MODIFIED="2008-08-13 10:53:09 +0200" MODIFIED_BY="Bernd Richter" NAME="Meliones 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-08-13 10:53:09 +0200" MODIFIED_BY="Bernd Richter" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jon N. Meliones, Frank W. Moler, Joseph R. Custer, Mary K. Dekeon, Robin A. Chapman, Robert H. Bartlett</AU>
<TI>Normalization of priming solution ionized calcium concentration improves hemodynamic stability of neonates receiving venovenous ECMO</TI>
<SO>ASAIO journal</SO>
<YR>1995</YR>
<VL>42</VL>
<NO>6</NO>
<PG>884-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Muangmingsuk-2001" NAME="Muangmingsuk 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;br&gt;All patients received calcium&lt;br&gt;Not ICU patients: CPB&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vorasri Muangmingsuk, Thomas F. Tremback, Sunthorn Muangmingsuk, David A. Roberson, Nancy E. Cipparrone</AU>
<TI>The effect on the hemodynamic stability of varying calcium chloride administration during protamine infusion in pediatric open-heart patients</TI>
<SO>Anesthesia Analgesia</SO>
<YR>2001</YR>
<VL>93</VL>
<PG>92-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Royster-1992" NAME="Royster 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not ICU patients: post-CPB&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rogert L. Royster, John F. Butterworth IV, Richard C. Prielipp, Paul G. Robertie, Neal D. Kon, William Y. Tucker, Louise M. Dudas, Gary P. Zaloga</AU>
<TI>A randomized, blinded, placebo-controlled evaluation of calcium chloride and epinephrine for inotropic support after emergence from cardiopulmonary bypass</TI>
<SO>Cardiovascular Anesthesia</SO>
<YR>1992</YR>
<VL>74</VL>
<PG>3-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shapira-1984" NAME="Shapira 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Exclusion criter:&lt;/p&gt;&lt;p&gt;Not a RCT or CCT&lt;br&gt;Not ICU patients: post-CPB&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nadiv Shapira, Hartzell V. Schall, Roger D. White, James R. Pluth</AU>
<TI>Hemodynamic effects of calcium chloride injection following cardiopulmonary bypass: response to bolus injection and continuous infusion</TI>
<SO>The Annals of Thoracic Surgery</SO>
<YR>1984</YR>
<VL>37</VL>
<NO>2</NO>
<PG>133-140</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Urban-1992" NAME="Urban 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Michael K. Urban, Roberta Hines</AU>
<TI>The effect of calcium on pulmonary vascular resistance and right ventricular function</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1992</YR>
<VL>104</VL>
<NO>2</NO>
<PG>327-332</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Venkataraman-1991" NAME="Venkataraman 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not a RCT or CCT&lt;br&gt;All patients received calcium&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pankaja S. Venkataraman, Gerardo J. Sanchez, Michael K. Parker, Dale Altmiller</AU>
<TI>Effect of intravenous calcium infusions on serum chemistries in neonates</TI>
<SO>Journal of Pedatric Gastroenterology and Nutrition</SO>
<YR>1991</YR>
<VL>13</VL>
<NO>2</NO>
<PG>134-138</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vincent-1995" NAME="Vincent 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Exclusion criteria:&lt;/p&gt;&lt;p&gt;Not a RCT or CCT: no control&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>J. L. Vincent, P. Bredas, S. Jankowski, R. J. Kahn</AU>
<TI>Correction of hypocalcemia in the critically ill: what is the hemodynamic benefit</TI>
<SO>Intensive Care Medicine</SO>
<YR>1995</YR>
<VL>21</VL>
<PG>838-841</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-08-13 14:28:17 +0200" MODIFIED_BY="Bernd Richter">
<ADDITIONAL_REFERENCES MODIFIED="2008-08-13 14:28:17 +0200" MODIFIED_BY="Bernd Richter">
<REFERENCE ID="REF-ARDS-Network-2000" NAME="ARDS Network 2000" TYPE="JOURNAL_ARTICLE">
<AU>The Acute Respiratory Distress Syndrome Network</AU>
<TI>Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network</TI>
<SO>New England Journal of Medicine</SO>
<YR>2000</YR>
<VL>342</VL>
<NO>18</NO>
<PG>1301-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Aslam-2003" MODIFIED="2008-08-13 14:13:28 +0200" MODIFIED_BY="Bernd Richter" NAME="Aslam 2003" TYPE="BOOK">
<AU>Aslam S, Llack F</AU>
<SO>Hypercalcemia, Hypocalcemia, and other Divalent Cation Disorders</SO>
<YR>2003</YR>
<PB>WB Saunders</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bosson-1985" NAME="Bosson 1985" TYPE="JOURNAL_ARTICLE">
<AU>Bosson R; Kuenzig M, Schwartz SI</AU>
<TI>Verapamil improves cardiac function and increases survival in canine E. coli endotoxic shock</TI>
<SO>Circulatory Shock</SO>
<YR>1985</YR>
<VL>16</VL>
<NO>3</NO>
<PG>3307-316</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burchard-1990" MODIFIED="2008-08-11 13:07:49 +0200" MODIFIED_BY="Bernd Richter" NAME="Burchard 1990" TYPE="JOURNAL_ARTICLE">
<AU>Burchard KW, Gann DS, Colliton J, Forster J</AU>
<TI>Ionized calcium, parathormone, and mortality in critically ill surgical patients</TI>
<TO>Ionized calcium, parathormone, and mortality in critically ill surgical patients.</TO>
<SO>Annals of Surgery</SO>
<YR>1990</YR>
<VL>212</VL>
<NO>4</NO>
<PG>543-9; discussion 549-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carlon-1980" MODIFIED="2008-08-11 13:07:42 +0200" MODIFIED_BY="Bernd Richter" NAME="Carlon 1980" TYPE="JOURNAL_ARTICLE">
<AU>Carlon GC, Howland WS, Kahn RC, Schweizer O</AU>
<TI>Calcium chloride administration in normocalcemic critically ill patients</TI>
<SO>Criticial Care Medicine</SO>
<YR>1980</YR>
<VL>8</VL>
<NO>4</NO>
<PG>209-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carlstedt-1998" MODIFIED="2008-08-11 13:07:36 +0200" MODIFIED_BY="Bernd Richter" NAME="Carlstedt 1998" TYPE="JOURNAL_ARTICLE">
<AU>Carlstedt F, Lind L, Rastad J, Stjernstrom H, Wide L, Ljunghall S</AU>
<TI>Parathyroid hormone and ionized calcium levels are related to the severity of illness and survival in critically ill patients</TI>
<SO>European Journal of Clinical Investigation</SO>
<YR>1998</YR>
<VL>28</VL>
<NO>11</NO>
<PG>898-903</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carlstedt-2000" MODIFIED="2008-08-11 13:07:32 +0200" MODIFIED_BY="Bernd Richter" NAME="Carlstedt 2000" TYPE="JOURNAL_ARTICLE">
<AU>Carlstedt F, Eriksson M, Kiiski R, Larsson A, Lind L</AU>
<TI>Hypocalcemia during porcine endotoxemic shock: effects of calcium administration</TI>
<SO>Critical Care Medicine</SO>
<YR>2000</YR>
<VL>28</VL>
<NO>8</NO>
<PG>2909-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1960" NAME="Cohen 1960" TYPE="JOURNAL_ARTICLE">
<AU>Cohen J</AU>
<TI>A coefficient of agreement for nominal scales</TI>
<SO>Educational and Psychological Measurement</SO>
<YR>1960</YR>
<VL>20</VL>
<PG>37-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deakin-1991" NAME="Deakin 1991" TYPE="JOURNAL_ARTICLE">
<AU>Deakin CD, Fagan EA, Williams R.</AU>
<TI>Cytoprotective effects of calcium channel blockers. Mechanisms and potential applications in hepatocellular injury</TI>
<SO>Journal of Hepatology</SO>
<YR>1991</YR>
<VL>12</VL>
<NO>2</NO>
<PG>251-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Desai-1988" MODIFIED="2008-08-11 13:04:44 +0200" MODIFIED_BY="Bernd Richter" NAME="Desai 1988" TYPE="JOURNAL_ARTICLE">
<AU>Desai TK, Carlson RW, Thill-Baharozian M, Geheb MA</AU>
<TI>A direct relationship between ionized calcium and arterial pressure among patients in an intensive care unit</TI>
<SO>Critical Care Medicine</SO>
<YR>1988</YR>
<VL>16</VL>
<NO>6</NO>
<PG>578-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Drop-1975" MODIFIED="2008-08-11 13:04:41 +0200" MODIFIED_BY="Bernd Richter" NAME="Drop 1975" TYPE="JOURNAL_ARTICLE">
<AU>Drop LJ, Laver MB</AU>
<TI>Low plasma ionized calcium and response to calcium therapy in critically ill man</TI>
<SO>Anesthesiology</SO>
<YR>1975</YR>
<VL>43</VL>
<NO>3</NO>
<PG>300-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder G</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test.</TI>
<SO>British Medical Journal</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fekete-2001" MODIFIED="2008-08-11 13:04:20 +0200" MODIFIED_BY="Bernd Richter" NAME="Fekete 2001" TYPE="JOURNAL_ARTICLE">
<AU>Fekete Z, Hauser CJ, Adams JM, Adams CA, Jr., Forsythe RM, Hasko G et al</AU>
<TI>Injury-enhanced calcium mobilization in circulating rat neutrophils models human PMN responses</TI>
<SO>Shock</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>1</NO>
<PG>15-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Forman-1991" MODIFIED="2008-08-11 13:04:11 +0200" MODIFIED_BY="Bernd Richter" NAME="Forman 1991" TYPE="JOURNAL_ARTICLE">
<AU>Forman DT, Lorenzo L</AU>
<TI>Ionized calcium: its significance and clinical usefulness</TI>
<SO>Annals of Clinical Laboratory Science</SO>
<YR>1991</YR>
<VL>21</VL>
<NO>5</NO>
<PG>297-304</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fujita-1999" NAME="Fujita 1999" TYPE="JOURNAL_ARTICLE">
<AU>Fujita J, Tsuda K, Takeda T, Yu L, Fujimoto S, Kajikawa M, et al.</AU>
<TI>Nisoldipine improves the impaired erythrocyte deformability correlating with elevated intracellular free calcium-ion concentration and poor glycaemic control in NIDDM</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>1999</YR>
<VL>47</VL>
<NO>5</NO>
<PG>499-506</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hammer-1998" MODIFIED="2008-08-13 14:14:07 +0200" MODIFIED_BY="Bernd Richter" NAME="Hammer 1998" TYPE="BOOK">
<AU>Hammer M, Brennan S, Lederer E</AU>
<SO>Severe Electrolyte Disorders</SO>
<YR>1998</YR>
<PB>McGraw Hill</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hastbacka-2003" MODIFIED="2008-08-11 13:04:07 +0200" MODIFIED_BY="Bernd Richter" NAME="Hastbacka 2003" TYPE="JOURNAL_ARTICLE">
<AU>Hastbacka J, Pettila V</AU>
<TI>Prevalence and predictive value of ionized hypocalcemia among critically ill patients</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2003</YR>
<VL>47</VL>
<NO>10</NO>
<PG>1264-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hauser-2000" MODIFIED="2008-08-11 13:04:04 +0200" MODIFIED_BY="Bernd Richter" NAME="Hauser 2000" TYPE="JOURNAL_ARTICLE">
<AU>Hauser CJ, Fekete Z, Livingston DH, Adams J, Garced M, Deitch EA</AU>
<TI>Major trauma enhances store-operated calcium influx in human neutrophils</TI>
<SO>Journal of Trauma</SO>
<YR>2000</YR>
<VL>48</VL>
<NO>4</NO>
<PG>592-7; discussion 597-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analysis</TI>
<SO>British Medical Journal</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Horton-1999" MODIFIED="2008-08-11 13:03:59 +0200" MODIFIED_BY="Bernd Richter" NAME="Horton 1999" TYPE="JOURNAL_ARTICLE">
<AU>Horton JW, White DJ, Maass D, Sanders B, Thompson M, Giroir B</AU>
<TI>Calcium antagonists improve cardiac mechanical performance after thermal trauma</TI>
<SO>Journal of Surgical Research</SO>
<YR>1999</YR>
<VL>87</VL>
<NO>1</NO>
<PG>39-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hotchkiss-1994" MODIFIED="2008-08-11 13:03:56 +0200" MODIFIED_BY="Bernd Richter" NAME="Hotchkiss 1994" TYPE="JOURNAL_ARTICLE">
<AU>Hotchkiss RS, Karl IE</AU>
<TI>Dantrolene ameliorates the metabolic hallmarks of sepsis in rats and improves survival in a mouse model of endotoxemia</TI>
<SO>Proceedings of the National Academy of Sciences of the United States of America</SO>
<YR>1994</YR>
<VL>91</VL>
<NO>8</NO>
<PG>3039-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hotchkiss-1996" MODIFIED="2008-08-11 13:03:52 +0200" MODIFIED_BY="Bernd Richter" NAME="Hotchkiss 1996" TYPE="JOURNAL_ARTICLE">
<AU>Hotchkiss RS, Karl IE</AU>
<TI>Calcium: a regulator of the inflammatory response in endotoxemia and sepsis</TI>
<SO>New Horizons</SO>
<YR>1996</YR>
<VL>4</VL>
<NO>1</NO>
<PG>58-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hugtenburg-1990" MODIFIED="2008-08-13 14:25:42 +0200" MODIFIED_BY="Bernd Richter" NAME="Hugtenburg 1990" TYPE="JOURNAL_ARTICLE">
<AU>Hugtenburg JG, Van Voorst MJ, Van Marle J, Mathy MJ, Beckeringh JJ, Van Veen HA, Hendriks MG, Van Zwieten PA</AU>
<TI>The influence of nifedipine and mioflazine on mitochondrial calcium overload in normoxic and ischaemic guinea pig hearts</TI>
<SO>European Journal of Pharmacology</SO>
<YR>1990</YR>
<VL>178</VL>
<PG>71-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" NAME="Jadad 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al</AU>
<TI>Assessing the quality of reports of randomized clinical trials: Is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lee-1986" MODIFIED="2008-08-13 14:15:12 +0200" MODIFIED_BY="Bernd Richter" NAME="Lee 1986" TYPE="JOURNAL_ARTICLE">
<AU>Lee HC, Lum BK</AU>
<TI>Protective action of calcium entry blockers in endotoxin shock</TI>
<SO>Circulatory Shock</SO>
<YR>1986</YR>
<VL>18</VL>
<PG>193-203</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Malcolm-1989" MODIFIED="2008-08-11 13:03:40 +0200" MODIFIED_BY="Bernd Richter" NAME="Malcolm 1989" TYPE="JOURNAL_ARTICLE">
<AU>Malcolm DS, Zaloga GP, Holaday JW</AU>
<TI>Calcium administration increases the mortality of endotoxic shock in rats</TI>
<SO>Critical Care Medicine</SO>
<YR>1989</YR>
<VL>17</VL>
<NO>9</NO>
<PG>900-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marino-1998" MODIFIED="2008-08-13 14:14:07 +0200" MODIFIED_BY="Bernd Richter" NAME="Marino 1998" TYPE="BOOK">
<AU>Marino PL</AU>
<SO>Calcium and Phosphorus</SO>
<YR>1998</YR>
<PB>Williams and Wilkins</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Meissner-1995" MODIFIED="2008-08-13 14:09:14 +0200" MODIFIED_BY="Bernd Richter" NAME="Meissner 1995" TYPE="JOURNAL_ARTICLE">
<AU>Meissner A, Morgan JP</AU>
<TI>Contractile function and abnormal Ca2+ modulation during postischemic reperfusion in rat heart</TI>
<SO>American Journal of Physiology</SO>
<YR>1995</YR>
<VL>268</VL>
<PG>H100-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Porter-1983" MODIFIED="2008-08-11 13:03:34 +0200" MODIFIED_BY="Bernd Richter" NAME="Porter 1983" TYPE="JOURNAL_ARTICLE">
<AU>Porter DL, Ledgerwood AM, Lucas CE, Harrigan CM</AU>
<TI>Effect of calcium infusion on heart function</TI>
<SO>American Surgeon</SO>
<YR>1983</YR>
<VL>49</VL>
<NO>7</NO>
<PG>369-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rose-1992" MODIFIED="2008-08-11 13:03:29 +0200" MODIFIED_BY="Bernd Richter" NAME="Rose 1992" TYPE="JOURNAL_ARTICLE">
<AU>Rose S, Thompson KD, Sayeed MM</AU>
<TI>Ca(2+)-related hepatocellular alterations during intra-abdominal sepsis</TI>
<SO>American Journal of Physiology</SO>
<YR>1992</YR>
<VL>263</VL>
<NO>3 Pt 2</NO>
<PG>R553-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Royster-1992" MODIFIED="2008-08-11 13:03:24 +0200" MODIFIED_BY="Bernd Richter" NAME="Royster 1992" TYPE="JOURNAL_ARTICLE">
<AU>Royster RL, Butterworth JFt, Prielipp RC, Robertie PG, Kon ND, Tucker WY et al</AU>
<TI>A randomized, blinded, placebo-controlled evaluation of calcium chloride and epinephrine for inotropic support after emergence from cardiopulmonary bypass</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1992</YR>
<VL>74</VL>
<NO>1</NO>
<PG>3-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sayeed-1986" MODIFIED="2008-08-11 13:03:19 +0200" MODIFIED_BY="Bernd Richter" NAME="Sayeed 1986" TYPE="JOURNAL_ARTICLE">
<AU>Sayeed MM</AU>
<TI>Alterations in cellular Ca2+ regulation in the liver in endotoxic shock</TI>
<SO>American Journal of Physiology</SO>
<YR>1986</YR>
<VL>250</VL>
<NO>5 Pt 2</NO>
<PG>R884-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sayeed-2000" MODIFIED="2008-08-11 13:03:11 +0200" MODIFIED_BY="Bernd Richter" NAME="Sayeed 2000" TYPE="JOURNAL_ARTICLE">
<AU>Sayeed MM</AU>
<TI>Exuberant Ca(2+) Signaling in Neutrophils: A Cause for Concern</TI>
<SO>News in Physiological Sciences</SO>
<YR>2000</YR>
<VL>15</VL>
<PG>130-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1995</YR>
<VL>273</VL>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Song-1993" MODIFIED="2008-08-11 13:03:02 +0200" MODIFIED_BY="Bernd Richter" NAME="Song 1993" TYPE="JOURNAL_ARTICLE">
<AU>Song SK, Karl IE, Ackerman JJ, Hotchkiss RS</AU>
<TI>Increased intracellular Ca2+: a critical link in the pathophysiology of sepsis?</TI>
<SO>Proceedings of the National Academy of Sciences of the United States of America</SO>
<YR>1993</YR>
<VL>90</VL>
<NO>9</NO>
<PG>3933-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sowemimo_x002d_Coker-1985" MODIFIED="2008-08-13 14:27:42 +0200" MODIFIED_BY="Bernd Richter" NAME="Sowemimo-Coker 1985" TYPE="JOURNAL_ARTICLE">
<AU>Sowemimo-Coker SO, Kovacs IB, Kirby JD, Turner P</AU>
<TI>Effects of verapamil on calcium-induced rigidity and on filterability of red blood cells from healthy volunteers and patients with progressive systemic sclerosis</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>1985</YR>
<VL>19</VL>
<NO>6</NO>
<PG>731-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spitzer-1986" MODIFIED="2008-08-11 13:02:58 +0200" MODIFIED_BY="Bernd Richter" NAME="Spitzer 1986" TYPE="JOURNAL_ARTICLE">
<AU>Spitzer JA, Deaciuc IV</AU>
<TI>Effect of endotoxicosis and sepsis on intracellular calcium homeostasis in rat liver. Mitochondrial and microsomal calcium uptake</TI>
<SO>Circulatory Shock</SO>
<YR>1986</YR>
<VL>18</VL>
<NO>2</NO>
<PG>81-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Takala-1999" MODIFIED="2008-08-13 14:28:03 +0200" MODIFIED_BY="Bernd Richter" NAME="Takala 1999" TYPE="JOURNAL_ARTICLE">
<AU>Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vunderlinckx G, Hinds CJ</AU>
<TI>Increased mortality associated with growth hormone treatment in critically ill adults</TI>
<SO>New England Journal of Medicine</SO>
<YR>1999</YR>
<VL>341</VL>
<NO>11</NO>
<PG>785-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tanonaka-1999" MODIFIED="2008-08-13 14:28:17 +0200" MODIFIED_BY="Bernd Richter" NAME="Tanonaka 1999" TYPE="JOURNAL_ARTICLE">
<AU>Tanonaka K, Kajiwara H, Kameda H, Takasaki A, Takeo A</AU>
<TI>Relationship between myocardial cation content and injury in reperfused rat hearts treated with cation channel blockers</TI>
<SO>European Journal of Pharmacology</SO>
<YR>1999</YR>
<VL>372</VL>
<NO>1</NO>
<PG>37-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Thompson-2000" MODIFIED="2008-08-13 14:10:20 +0200" MODIFIED_BY="Bernd Richter" NAME="Thompson 2000" TYPE="JOURNAL_ARTICLE">
<AU>Thompson M, Kliewer A, Maass D, Becker L, White DJ, Bryant D, Arteaga G, Jorton J, Giroir BP</AU>
<TI>Increased cardiomyocyte intracellular calcium during endotoxin-induced cardiac dysfunction in guinea pigs</TI>
<SO>Pediatric Research</SO>
<YR>2000</YR>
<VL>47</VL>
<PG>669-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tomera-1992" MODIFIED="2008-08-11 13:02:53 +0200" MODIFIED_BY="Bernd Richter" NAME="Tomera 1992" TYPE="JOURNAL_ARTICLE">
<AU>Tomera JF, Friend KD, Kukulka SP, Lilford K</AU>
<TI>Modification of calcium flux of twitch skeletal muscle in mice subjected to 20% body surface area burn</TI>
<SO>The Journal of Burn Care and Rehabilitation</SO>
<YR>1992</YR>
<VL>13</VL>
<NO>5</NO>
<PG>546-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Venkataraman-1985" MODIFIED="2008-08-11 13:02:44 +0200" MODIFIED_BY="Bernd Richter" NAME="Venkataraman 1985" TYPE="JOURNAL_ARTICLE">
<AU>Venkataraman PS, Wilson DA, Sheldon RE, Rao R, Parker MK</AU>
<TI>Effect of hypocalcemia on cardiac function in very-low-birth-weight preterm neonates: studies of blood ionized calcium, echocardiography, and cardiac effect of intravenous calcium therapy</TI>
<SO>Pediatrics</SO>
<YR>1985</YR>
<VL>76</VL>
<NO>4</NO>
<PG>543-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vincent-1995" MODIFIED="2008-08-11 13:02:39 +0200" MODIFIED_BY="Bernd Richter" NAME="Vincent 1995" TYPE="JOURNAL_ARTICLE">
<AU>Vincent JL, Bredas P, Jankowski S, Kahn RJ</AU>
<TI>Correction of hypocalcaemia in the critically ill: what is the haemodynamic benefit?</TI>
<SO>Intensive Care Med</SO>
<YR>1995</YR>
<VL>21</VL>
<NO>10</NO>
<PG>838-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-White-2002" MODIFIED="2008-08-11 13:02:33 +0200" MODIFIED_BY="Bernd Richter" NAME="White 2002" TYPE="JOURNAL_ARTICLE">
<AU>White DJ, Maass DL, Sanders B, Horton JW</AU>
<TI>Cardiomyocyte intracellular calcium and cardiac dysfunction after burn trauma</TI>
<SO>Critical Care Medicine</SO>
<YR>2002</YR>
<VL>30</VL>
<NO>1</NO>
<PG>14-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zaloga-1987" MODIFIED="2008-08-11 13:02:29 +0200" MODIFIED_BY="Bernd Richter" NAME="Zaloga 1987" TYPE="JOURNAL_ARTICLE">
<AU>Zaloga GP, Chernow B</AU>
<TI>The multifactorial basis for hypocalcemia during sepsis. Studies of the parathyroid hormone-vitamin D axis</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1987</YR>
<VL>107</VL>
<NO>1</NO>
<PG>36-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zaloga-1992" MODIFIED="2008-08-11 13:02:23 +0200" MODIFIED_BY="Bernd Richter" NAME="Zaloga 1992" TYPE="JOURNAL_ARTICLE">
<AU>Zaloga GP</AU>
<TI>Hypocalcemia in critically ill patients</TI>
<SO>Critical Care Medicine</SO>
<YR>1992</YR>
<VL>20</VL>
<NO>2</NO>
<PG>251-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zaloga-1993" MODIFIED="2008-08-13 14:11:11 +0200" MODIFIED_BY="Bernd Richter" NAME="Zaloga 1993" TYPE="JOURNAL_ARTICLE">
<AU>Zaloga GP, Washburn D, Black KW, Prielipp R</AU>
<TI>Human sepsis increases lymphocyte intracellular calcium</TI>
<SO>Critical Care Medicine</SO>
<YR>1993</YR>
<VL>21</VL>
<PG>196-202</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zivin-2001" MODIFIED="2008-08-11 13:02:15 +0200" MODIFIED_BY="Bernd Richter" NAME="Zivin 2001" TYPE="JOURNAL_ARTICLE">
<AU>Zivin JR, Gooley T, Zager RA, Ryan MJ</AU>
<TI>Hypocalcemia: a pervasive metabolic abnormality in the critically ill</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>2001</YR>
<VL>37</VL>
<NO>4</NO>
<PG>689-98</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-08-13 23:28:21 +0200" MODIFIED_BY="Bernd Richter">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-08-13 10:41:22 +0200" MODIFIED_BY="Bernd Richter" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-08-13 10:41:08 +0200" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Auffant-1981">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Thirty male patients undergoing elective procedures requiring cardiopulmonary bypass and admitted to the ICU postoperatively.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Intervention focused primarily upon determining whether or not intravenous calcium chloride could alter ionized calcium concentration and hemodynamics. Subjects with hypocalcemia (ionized calcium concentration &lt; 1.8 mEq/L) postoperatively were included and randomized to receive the following interventions: 1) calcium chloride (10%) intermittent IV bolus at a dose of 5mg/kg when ionized calcium concentration was less than 1.8 mEq/L; 2) calcium chloride (10%) by continuous infusion until ionized calcium concentration exceeded 1.8 mEq/L; or 3) no calcium chloride regardless of ionized calcium chloride concentration. Subjects were followed for 2 hours postoperatively and serum ionized calcium concentration was measured preoperatively, during cardiopulmonary bypass, and every 15 minutes after admission to the ICU.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Ionized calcium concentration.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-13 10:41:08 +0200" MODIFIED_BY="Bernd Richter"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-13 10:41:12 +0200" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Butterworth-1992">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Forty six adult patients scheduled for elective aortocoronary bypass surgery, who were admitted to the ICU postoperatively and were extubated and hemodynamically stable on their first postoperative day.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>The intervention focused primarily upon determining the effect of calcium adminstration on dobutamine's and amrinone's hemodynamic actions in a hemodynamically stable population of post-cardiopulmonary bypass patients. In the Dobutamine-Calcium group, subjects were assigned to receive the following interventions: 1) saline solution; or 2) calcium chloride at 1mg/kg.min. After 20 minutes the infusion was reduced to 0.25mg/kg/min to maintain a "stable elevated ionized calcium concentration (~50% increase). Serum ionized calcium concentration was measured at baseline, 6 and 12 minutes later, at 25 minutes after calcium administration and then 6 and 12 minutes later. In the Amrinone-Calcium group, subjects were assigned to receive the following interventions: 1) saline solution; or 2) calcium chloride at a rate of 1mg/kg/min for 20 minutes. Serum ionized calcium concentration was measured at baseline, 10 and 20 minutes later, and at 5, 10, 15 and 20 minutes after calcium chloride administration.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Ionized calcium concentration.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-13 10:41:12 +0200" MODIFIED_BY="Bernd Richter"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-13 10:41:16 +0200" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Porcelli-1995">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Forty-three infants with a gestational age of 36 weeks or less and a total serum calcium concentration of 7.0 mg/dL(1.75 mmol/L) or less within 72 hours of life.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Intervention focused primarily on examining the relationship between total serum calcium, ionized serum calcium, and hypocalcemia signs, and their response to a single calcium gluconate infusion in preterm hypocalcemic infants. Subjects were assigned to receive intravenously over a 30- to 60- minute period the following interventions: 1) calcium gluconate (100mg/mL) at a 1mL/kg dose ; 2) normal saline solution. Total and ionized calcium concentration were measured pretreatment and 3 to 6 hours after treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Ionized calcium concentration</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-13 10:41:16 +0200" MODIFIED_BY="Bernd Richter"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-13 10:41:19 +0200" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Scott-1984">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Twenty seven infants with neonatal hypocalcemia and a serum total calcium concetration &lt; 6.0 mg/dl, who were admitted to the Neonatal Intensive Care Unit.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Intervention was focused primarily on whether or not intravenous calcium gluconate can alter serum ionized calcium concentration. Neonates were randomized to the following protocols: 1) bolus treatment: 200mg/kg calcium gluconate intravenously every 6 hours at a rate of 100mg/min; 2) drip group: 400 mg calcium gluconate/kg/day as a continuous infusion; 3) control group: no additional calcium. If ionized calcium concentration was &lt; 2.5mg/dl the subject was assigned to either the bolus or drip group.When ionized calcium concentration exceeded 3.5mg/dL on two consecutive measurements, the infant was removed from treatment. Subjects were followed for 72 hours after enrollment. Ionized calcium concentration measured every 6 hours dring period of observation and then daily until 72 hours of observation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Ionized calcium concentration.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-13 10:41:19 +0200" MODIFIED_BY="Bernd Richter"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-13 10:41:22 +0200" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Zaloga-1990">
<CHAR_METHODS>
<P>RCT crossover design.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Twelve patients recovering and hemodynamically stable from coronary artery bypass surgery were studied on their first postoperative day in the ICU.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Intervention focused primarily on evaluating the effect of calcium on epinephrine's cardiovascular and metabolic actions in patients recovering from aortocoronayr bypass surgery, who were extubated and hemodynamically stable. Each patient received calcium chloride infusion (10mg/Kg bolus over 5 minutes followed by a 2mg/Kg/hr infusion) or a comparable volume of D5W as the initial infusion. After either of these interventions subjects received epinephrine infusions (10ng/kg/min and 30ng/kg/min) administered incrementally for 8 minutes eadch. Serum ionized calcium concentration was measured at baseline, 10, 20, 24, 28, 32, and 36 minutes after initiation of the study.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Ionized calcium concentration.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-13 10:41:22 +0200" MODIFIED_BY="Bernd Richter"/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-08-13 23:28:21 +0200" MODIFIED_BY="Bernd Richter" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Broner-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>No placebo control cohort</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-11 13:08:39 +0200" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Castillo-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-11 13:08:39 +0200" MODIFIED_BY="Bernd Richter">
<P>Outcomes of interest not assessed</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cote_x0027_-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control cohort</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cote_x0027_-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control cohort</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-12 12:28:54 +0200" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-d_x0027_Hollander">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-12 12:28:54 +0200" MODIFIED_BY="Bernd Richter">
<P>Not intensive care unit (ICU) patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Diaz-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control cohort<BR/>Not ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Drop-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control cohort</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ekery-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gallagher-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Guideri-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control cohort<BR/>Not ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Johnston-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kramer-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an evaluation of calcium supplementation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lijima-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control cohort</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Martin-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control cohort<BR/>Not ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Meliones-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control cohort</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Meliones-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control cohort</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 23:28:21 +0200" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Muangmingsuk-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 23:28:21 +0200" MODIFIED_BY="Bernd Richter">
<P>No control cohort<BR/>Not ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Royster-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Shapira-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Urban-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Venkataraman-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control cohort</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vincent-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control cohort</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-08-12 12:28:32 +0200" MODIFIED_BY="Bernd Richter">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-08-12 12:28:32 +0200" MODIFIED_BY="Bernd Richter" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-12 12:28:26 +0200" MODIFIED_BY="Bernd Richter" RESULT="UNKNOWN" STUDY_ID="STD-Auffant-1981">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-12 12:28:28 +0200" MODIFIED_BY="Bernd Richter" RESULT="UNKNOWN" STUDY_ID="STD-Butterworth-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-12 12:28:32 +0200" MODIFIED_BY="Bernd Richter" RESULT="UNKNOWN" STUDY_ID="STD-Porcelli-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-11 13:09:10 +0200" MODIFIED_BY="Bernd Richter" RESULT="UNKNOWN" STUDY_ID="STD-Scott-1984">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-11 13:09:13 +0200" MODIFIED_BY="Bernd Richter" RESULT="UNKNOWN" STUDY_ID="STD-Zaloga-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-08-13 14:34:04 +0200" MODIFIED_BY="Bernd Richter">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2008-08-13 14:34:04 +0200" MODIFIED_BY="Bernd Richter" NO="1">
<TITLE>Methods of calcium administration and measurement of calcium concentration</TITLE>
<TABLE COLS="5" ROWS="6">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Indication</P>
</TH>
<TH>
<P>Method</P>
</TH>
<TH>
<P>Calcium measurement</P>
</TH>
<TH>
<P/>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Auffant-1981" TYPE="STUDY">Auffant 1981</LINK>
</P>
</TD>
<TD>
<P>[Ca<SUP>2+</SUP>]i &lt; 0.9 mmol/L</P>
</TD>
<TD>
<P>Calcium chloride<BR/>
</P>
<P>Bolus (n=10): 5 mg/kg Infusion (n=7): 0.5 mg/kg/min</P>
</TD>
<TD>
<P>Preoperatively, during surgery, and every 15 minutes for 2 hours after beginning calcium administration</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Butterworth-1992" TYPE="STUDY">Butterworth 1992</LINK>
</P>
</TD>
<TD>
<P>Prophylaxis</P>
</TD>
<TD>
<P>Calcium chloride<BR/>
<BR/>Group 1: 1 mg/kg/min for 20 minutes followed by 0.25 mg/kg/min for 5 minutes<BR/>
<BR/>Group 2: 1 mg/kg/min for 20 minutes<BR/>
</P>
</TD>
<TD>
<P>
<BR/>
<BR/>Group 1: baseline, 25, 31, and 37 minutes after beginning calcium administration<BR/>
<BR/>Group 2: baseline, every 5 minutes for 20 minutes after beginning calcium adminstration</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Porcelli-1995" TYPE="STUDY">Porcelli 1995</LINK>
</P>
</TD>
<TD>
<P>[Ca]t &lt; 1.75 mmol/L</P>
</TD>
<TD>
<P>Calcium gluconate<BR/>
<BR/>100 mg/kg infused over 30-60 minutes<BR/>
<BR/>
</P>
</TD>
<TD>
<P>One measurement at 3-6 hours after administration</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Scott-1984" TYPE="STUDY">Scott 1984</LINK>
</P>
</TD>
<TD>
<P>[Ca<SUP>2+</SUP>]i &lt; 0.63 mmol/dL</P>
</TD>
<TD>
<P>Calcium gluconate<BR/>
<BR/>Bolus: 200 mg/kg every 6 hours at 100 mg/min<BR/>
<BR/>Infusion: 400 mg/kg/24h (~0.278 mg/kg/min)</P>
</TD>
<TD>
<P>
<BR/>
<BR/>Every 6 hours for 24 hours after beginning calcium administration<BR/>
<BR/>
<BR/>Every 6 hours for 24 hours after beginning calcium administration</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zaloga-1990" TYPE="STUDY">Zaloga 1990</LINK>
</P>
</TD>
<TD>
<P>Prophylaxis</P>
</TD>
<TD>
<P>Calcium chloride<BR/>
<BR/>10 mg/kg bolus followed by 2 mg/kg/h</P>
</TD>
<TD>
<P>Baseline, 10, 20, 24, 32, 36, and 44 minutes after beginning calcium administration</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>[Ca<SUP>2+</SUP>]i = ionized calcium concentration</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Calcium vs. placebo</NAME>
<CONT_OUTCOME CHI2="39.08726030448001" CI_END="0.487129892217284" CI_START="-0.0016500258078033236" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.24273993320474033" ESTIMABLE="YES" I2="94.88324332680136" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="3.2532416760489014E-9" P_Q="1.0" P_Z="0.05156698450121479" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.044017252177147484" TOTALS="YES" TOTAL_1="41" TOTAL_2="42" UNITS="" WEIGHT="100.00000000000001" Z="1.9467310711670045">
<NAME>Calcium vs. placebo (infusion, early)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.13025855307430215" CI_START="0.009741446925697748" EFFECT_SIZE="0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.97" MEAN_2="0.9" ORDER="26060" SD_1="0.07" SD_2="0.03" SE="0.03074472467331746" STUDY_ID="STD-Auffant-1981" TOTAL_1="6" TOTAL_2="7" WEIGHT="34.5796169537278"/>
<CONT_DATA CI_END="0.6206819768187964" CI_START="0.3793180231812036" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="1.64" MEAN_2="1.14" ORDER="26061" SD_1="0.26" SD_2="0.14" SE="0.06157356858121906" STUDY_ID="STD-Butterworth-1992" TOTAL_1="23" TOTAL_2="23" WEIGHT="32.521075805596396"/>
<CONT_DATA CI_END="0.281591796340129" CI_START="0.0584082036598713" EFFECT_SIZE="0.17000000000000015" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.13" ORDER="26062" SD_1="0.17" SD_2="0.1" SE="0.05693563617512908" STUDY_ID="STD-Zaloga-1990" TOTAL_1="12" TOTAL_2="12" WEIGHT="32.89930724067582"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.078904948615452" CI_END="0.2599132554920159" CI_START="-0.016820016853215505" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.12154661931940018" ESTIMABLE="YES" I2="75.2441696898197" I2_Q="0.0" ID="CMP-001.02" NO="2" P_CHI2="0.017607170024396823" P_Q="1.0" P_Z="0.08512235945752805" Q="0.0" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.010913990920969298" TOTALS="YES" TOTAL_1="37" TOTAL_2="37" UNITS="" WEIGHT="100.0" Z="1.72170837492523">
<NAME>Calcium vs. placebo (infusion, late)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.40327480587285647" CI_START="0.13672519412714335" EFFECT_SIZE="0.2699999999999999" ESTIMABLE="YES" MEAN_1="1.15" MEAN_2="0.88" ORDER="26063" SD_1="0.16" SD_2="0.05" SE="0.06799859942535232" STUDY_ID="STD-Auffant-1981" TOTAL_1="6" TOTAL_2="7" WEIGHT="32.07576658353613"/>
<CONT_DATA CI_END="0.12381506144378757" CI_START="0.016184938556212565" EFFECT_SIZE="0.07000000000000006" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="0.73" ORDER="26064" SD_1="0.09" SD_2="0.09" SE="0.027457168533847474" STUDY_ID="STD-Porcelli-1995" TOTAL_1="22" TOTAL_2="21" WEIGHT="42.71440572111973"/>
<CONT_DATA CI_END="0.20444037519218988" CI_START="-0.16444037519218985" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="0.86" ORDER="26065" SD_1="0.26" SD_2="0.11" SE="0.09410396142328736" STUDY_ID="STD-Scott-1984" TOTAL_1="9" TOTAL_2="9" WEIGHT="25.20982769534414"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.11329467314280195" CI_START="0.04670532685719798" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.07999999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="2.484769056528494E-6" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="7" UNITS="" WEIGHT="100.0" Z="4.709375523546848">
<NAME>Calcium vs. placebo (bolus, early)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.11329467314280195" CI_START="0.04670532685719798" EFFECT_SIZE="0.07999999999999996" ESTIMABLE="YES" MEAN_1="0.98" MEAN_2="0.9" ORDER="26066" SD_1="0.04" SD_2="0.03" SE="0.01698739028136543" STUDY_ID="STD-Auffant-1981" TOTAL_1="10" TOTAL_2="7" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.752504692489578" CI_END="0.12076416253221978" CI_START="-0.014457944069406294" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.05315310923140674" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" NO="4" P_CHI2="0.3856844206209744" P_Q="1.0" P_Z="0.1233544195375395" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="19" TOTAL_2="16" UNITS="" WEIGHT="100.0" Z="1.540845389530826">
<NAME>Calcium vs. placebo (bolus, late)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.14758939845016983" CI_START="-0.007589398450169926" EFFECT_SIZE="0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.95" MEAN_2="0.88" ORDER="26067" SD_1="0.11" SD_2="0.05" SE="0.03958715520396556" STUDY_ID="STD-Auffant-1981" TOTAL_1="10" TOTAL_2="7" WEIGHT="75.93301318772396"/>
<CONT_DATA CI_END="0.13781828516036315" CI_START="-0.13781828516036315" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.86" MEAN_2="0.86" ORDER="26068" SD_1="0.18" SD_2="0.11" SE="0.07031674369909661" STUDY_ID="STD-Scott-1984" TOTAL_1="9" TOTAL_2="9" WEIGHT="24.066986812276042"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.7520007234254207" CI_END="0.10994738666417464" CI_START="0.01115493281857629" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.06055115974137546" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.05" NO="5" P_CHI2="0.38584356160401945" P_Q="1.0" P_Z="0.01628013866670896" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="40" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="2.4025740366912696">
<NAME>Calcium vs. placebo (neonates)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.12381506144378757" CI_START="0.016184938556212565" EFFECT_SIZE="0.07000000000000006" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="0.73" ORDER="26069" SD_1="0.09" SD_2="0.09" SE="0.027457168533847474" STUDY_ID="STD-Porcelli-1995" TOTAL_1="22" TOTAL_2="21" WEIGHT="84.25193290229235"/>
<CONT_DATA CI_END="0.1344744307483789" CI_START="-0.11447443074837889" EFFECT_SIZE="0.010000000000000009" ESTIMABLE="YES" MEAN_1="0.87" MEAN_2="0.86" ORDER="26070" SD_1="0.22" SD_2="0.11" SE="0.06350852961085883" STUDY_ID="STD-Scott-1984" TOTAL_1="18" TOTAL_2="9" WEIGHT="15.748067097707645"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.657708097551045" CI_END="0.15566746561298506" CI_START="0.016874778720160563" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.08627112216657282" ESTIMABLE="YES" I2="57.06042632745554" I2_Q="0.0" ID="CMP-001.06" NO="6" P_CHI2="0.09740748939000954" P_Q="1.0" P_Z="0.014827746094983251" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.002101725412582398" TOTALS="YES" TOTAL_1="56" TOTAL_2="37" UNITS="" WEIGHT="99.99999999999999" Z="2.436559103188305">
<NAME>Calcium vs. placebo (hypocalcemia)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.22368507622427697" CI_START="0.07631492377572308" EFFECT_SIZE="0.15000000000000002" ESTIMABLE="YES" MEAN_1="1.03" MEAN_2="0.88" ORDER="26071" SD_1="0.13" SD_2="0.05" SE="0.03759511746414496" STUDY_ID="STD-Auffant-1981" TOTAL_1="16" TOTAL_2="7" WEIGHT="35.66457486927136"/>
<CONT_DATA CI_END="0.12381506144378757" CI_START="0.016184938556212565" EFFECT_SIZE="0.07000000000000006" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="0.73" ORDER="26072" SD_1="0.09" SD_2="0.09" SE="0.027457168533847474" STUDY_ID="STD-Porcelli-1995" TOTAL_1="22" TOTAL_2="21" WEIGHT="43.90119558265479"/>
<CONT_DATA CI_END="0.1344744307483789" CI_START="-0.11447443074837889" EFFECT_SIZE="0.010000000000000009" ESTIMABLE="YES" MEAN_1="0.87" MEAN_2="0.86" ORDER="26073" SD_1="0.22" SD_2="0.11" SE="0.06350852961085883" STUDY_ID="STD-Scott-1984" TOTAL_1="18" TOTAL_2="9" WEIGHT="20.43422954807383"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-08-13 10:39:17 +0200" MODIFIED_BY="Bernd Richter">
<APPENDIX ID="APP-01" MODIFIED="2008-08-13 10:39:17 +0200" MODIFIED_BY="Bernd Richter" NO="1">
<TITLE MODIFIED="2008-08-06 12:49:05 +0200" MODIFIED_BY="[Empty name]">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-08-13 10:39:17 +0200" MODIFIED_BY="Bernd Richter">
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>Search terms</P>
</TH>
</TR>
<TR>
<TD>
<P>Unless otherwise stated, search terms are free text terms; MeSH = Medical subject heading (Medline medical index term); exp = exploded MeSH; the dollar sign ($) stands for any character(s); the question mark (?) = to substitute for one or no characters; tw = text word; pt = publication type; sh = MeSH; adj = adjacent.</P>
<P>(1) exp Critical Care/<BR/>(2) exp Critical Illness/<BR/>(3) exp Multiple Organ Failure/<BR/>(4) exp Acid-Base Equilibrium/<BR/>(5) exp Intensive Care Units/<BR/>(6) exp Multiple Trauma/<BR/>(7) exp Perioperative Care/<BR/>(8) exp Resuscitation/<BR/>(9) exp Shock/<BR/>(10) exp sepsis/<BR/>(11) *"wounds and injuries"/<BR/>(12) sepsis.tw.<BR/>(13) ICU.tw.<BR/>(14) (critical adj (care or illness)).tw.<BR/>(15) (serious$ adj injur$).tw.<BR/>(16) multiple organ$ failure$.tw.<BR/>(17) acid-base equilibrium$.tw.<BR/>(18) hypocalc?emi$.tw.<BR/>(19) (severe adj (traum$ or shock)).tw.<BR/>(20) ((preoperative or perioperative) adj care).tw.<BR/>(21) exp Hypocalcemia/<BR/>(22) or/1-21<BR/>(23) exp Calcium/<BR/>(24) calcium.tw.<BR/>(25) 23 or 24<BR/>(26) 22 and 25<BR/>(27) randomized controlled trial.pt.<BR/>(28) controlled clinical trial.pt.<BR/>(29) randomized controlled trials.sh.<BR/>(30) random allocation.sh.<BR/>(31) double-blind method.sh.<BR/>(32) single-blind method.sh.<BR/>(33) or/27-32<BR/>(34) limit 33 to animal<BR/>(35) limit 33 to human [Limit not valid in: Ovid MEDLINE(R) In-Process &amp; Other Non-Indexed Citations; records were retained]<BR/>(36) 34 not 35<BR/>(37) 33 not 36<BR/>(38) clinical trial.pt.<BR/>(39) exp clinical trials/<BR/>(40) (clinic$ adj25 trial$).tw.<BR/>(41) ((singl$ or doubl$ or trebl$ or tripl$) adj (mask$ or blind$)).tw.<BR/>(42) placebos.sh.<BR/>(43) placebo$.tw.<BR/>(44) random$.tw.<BR/>(45) research design.sh.<BR/>(46) (latin adj square).tw.<BR/>(47) or/38-46<BR/>(48) limit 47 to animal<BR/>(49) limit 47 to human<BR/>(50) 48 not 49<BR/>(51) 47 not 50<BR/>(52) comparative study.sh.<BR/>(53) exp evaluation studies/<BR/>(54) follow-up studies.sh.<BR/>(55) prospective studies.sh.<BR/>(56) (control$ or prospectiv$ or volunteer$).tw.<BR/>(57) cross-over studies.sh.<BR/>(58) or/52-57<BR/>(59) limit 58 to animal<BR/>(60) limit 58 to human<BR/>(61) 59 not 60<BR/>(62) 58 not 61<BR/>(63) 37 or 51 or 62<BR/>(64) 26 and 63</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>